Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Opana ER: Effort To Expand US Label Might Lead To Withdrawal Due To Abuse Problems
Mar 10 2017
•
By
Sue Sutter
Have you checked out Pink Sheet podcast?
New episodes every Thursday.
More from US FDA Performance Tracker
More from Regulatory Trackers